CVRx, Inc. financial data

Symbol
CVRX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
9201 West Broadway Avenue, Suite 650, Minneapolis, MN
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.25K % -15.7%
Quick Ratio 135 % +35.4%
Debt-to-equity 51.2 % +196%
Return On Equity -77.6 % -86.5%
Return On Assets -51.3 % -44.7%
Operating Margin -125 % +15.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21.8M shares +4.96%
Common Stock, Shares, Outstanding 21.7M shares +4.63%
Entity Public Float 190M USD +163%
Common Stock, Value, Issued 217K USD +4.33%
Weighted Average Number of Shares Outstanding, Basic 21.6M shares +4.43%
Weighted Average Number of Shares Outstanding, Diluted 21.6M shares +4.43%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 44.4M USD +43.9%
Cost of Revenue 6.93M USD +21.6%
Research and Development Expense 10.8M USD -10.6%
Operating Income (Loss) -55.4M USD -21.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -54.2M USD -25.4%
Income Tax Expense (Benefit) 158K USD +23.4%
Net Income (Loss) Attributable to Parent -54.4M USD -25.3%
Earnings Per Share, Basic -2.57 USD/shares -22.4%
Earnings Per Share, Diluted -1.14 USD/shares +45.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 70.4M USD -22.5%
Accounts Receivable, after Allowance for Credit Loss, Current 8.61M USD +28%
Inventory, Net 11.2M USD +2.71%
Assets, Current 92M USD -17.9%
Property, Plant and Equipment, Net 2.76M USD +51.7%
Operating Lease, Right-of-Use Asset 1.2M USD +7.82%
Other Assets, Noncurrent 26K USD -3.7%
Assets 96M USD -16.5%
Accounts Payable, Current 3.52M USD +19.9%
Employee-related Liabilities, Current 270K USD
Accrued Liabilities, Current 5.61M USD -6.38%
Liabilities, Current 9.13M USD +2.25%
Operating Lease, Liability, Noncurrent 1.02M USD +8.14%
Other Liabilities, Noncurrent 1.27M USD +42.9%
Liabilities 40.7M USD +62.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -210K USD -12.3%
Retained Earnings (Accumulated Deficit) -514M USD -11.8%
Stockholders' Equity Attributable to Parent 55.2M USD -38.6%
Liabilities and Equity 96M USD -16.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.9M USD -6.31%
Net Cash Provided by (Used in) Financing Activities 1.36M USD -82%
Net Cash Provided by (Used in) Investing Activities -917K USD -282%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 21.7M shares
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.5M USD -258%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 70.4M USD -22.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 770K USD +310%
Deferred Tax Assets, Valuation Allowance 111M USD +8.56%
Deferred Tax Assets, Gross 111M USD +8.56%
Operating Lease, Liability 1.27M USD +12.3%
Depreciation 538K USD +5.28%
Payments to Acquire Property, Plant, and Equipment 917K USD +282%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -54.4M USD -25.5%
Lessee, Operating Lease, Liability, to be Paid 1.46M USD +13.2%
Property, Plant and Equipment, Gross 5.82M USD +34.1%
Operating Lease, Liability, Current 247K USD +33.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 362K USD +42%
Lessee, Operating Lease, Liability, to be Paid, Year One 350K USD +57%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 190K USD +19.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 374K USD +42.7%
Deferred Tax Assets, Operating Loss Carryforwards 89.2M USD +8.68%
Unrecognized Tax Benefits 2.22M USD +8.55%
Lessee, Operating Lease, Liability, to be Paid, Year Four 223K USD -17.4%
Operating Lease, Payments 100K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 16.8M USD +225%
Interest Expense 2.52M USD +522%